Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05194709
Recruitment Status : Recruiting
First Posted : January 18, 2022
Last Update Posted : February 2, 2022
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Information provided by (Responsible Party):
Wuxi People's Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2022
Estimated Study Completion Date : December 30, 2022